Cargando…
Metformin can mitigate skeletal dysplasia caused by Pck2 deficiency
As an important enzyme for gluconeogenesis, mitochondrial phosphoenolpyruvate carboxykinase (PCK2) has further complex functions beyond regulation of glucose metabolism. Here, we report that conditional knockout of Pck2 in osteoblasts results in a pathological phenotype manifested as craniofacial ma...
Autores principales: | Li, Zheng, Yue, Muxin, Heng, Boon Chin, Liu, Yunsong, Zhang, Ping, Zhou, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663691/ https://www.ncbi.nlm.nih.gov/pubmed/36376276 http://dx.doi.org/10.1038/s41368-022-00204-1 |
Ejemplares similares
-
The PCK2-glycolysis axis assists three-dimensional-stiffness maintaining stem cell osteogenesis
por: Li, Zheng, et al.
Publicado: (2022) -
Metformin does not slow cyst growth in the PCK rat model of polycystic kidney disease
por: Oto, Ozgur A., et al.
Publicado: (2023) -
Integrative Analysis Reveals the Diverse Effects of 3D Stiffness upon Stem Cell Fate
por: Yue, Muxin, et al.
Publicado: (2023) -
A novel mutation in PCK2 gene causes primary angle-closure glaucoma
por: Xu, Menghan, et al.
Publicado: (2021) -
PCK1 Deficiency Shortens the Replicative Lifespan of Saccharomyces cerevisiae through Upregulation of PFK1
por: Yuan, Yuan, et al.
Publicado: (2020)